EUR 11.55
(2.21%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 27.3 Million EUR | 11.37% |
2022 | 32.08 Million EUR | -3.56% |
2021 | 31.81 Million EUR | 35.24% |
2020 | 17.96 Million EUR | 15.21% |
2019 | 20.41 Million EUR | 22.3% |
2018 | 16.69 Million EUR | 281.12% |
2017 | 4.38 Million EUR | -4.18% |
2016 | 3.61 Million EUR | -12.47% |
2015 | 5.24 Million EUR | 95.95% |
2014 | 2.56 Million EUR | -33.34% |
2013 | 2.75 Million EUR | -38.72% |
2012 | 5.25 Million EUR | 66.68% |
2011 | 5.26 Million EUR | -27.07% |
2010 | 5.36 Million EUR | 765.06% |
2009 | -806 Thousand EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 11.55 Million EUR | -36.53% |
2023 FY | - EUR | 11.37% |
2023 Q2 | 12.73 Million EUR | -35.91% |
2023 Q4 | 21.43 Million EUR | 68.26% |
2022 Q4 | 19.87 Million EUR | 83.85% |
2022 FY | - EUR | -3.56% |
2022 Q2 | 10.8 Million EUR | -37.51% |
2021 Q2 | 14.51 Million EUR | -10.27% |
2021 FY | - EUR | 35.24% |
2021 Q4 | 17.29 Million EUR | 19.17% |
2020 Q4 | 16.17 Million EUR | 120.19% |
2020 Q2 | 7.34 Million EUR | -46.88% |
2020 FY | - EUR | 15.21% |
2019 Q4 | 13.82 Million EUR | 109.4% |
2019 FY | - EUR | 22.3% |
2019 Q2 | 6.6 Million EUR | -40.96% |
2018 Q4 | 11.18 Million EUR | 103.07% |
2018 Q2 | 5.5 Million EUR | 90.98% |
2018 FY | - EUR | 281.12% |
2017 FY | - EUR | -4.18% |
2017 Q4 | 2.88 Million EUR | 92.78% |
2017 Q2 | 1.49 Million EUR | 0.0% |
2016 FY | - EUR | -12.47% |
2015 FY | - EUR | 95.95% |
2014 FY | - EUR | -33.34% |
2013 FY | - EUR | -38.72% |
2012 FY | - EUR | 66.68% |
2011 FY | - EUR | -27.07% |
2010 FY | - EUR | 765.06% |
2009 FY | - EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Biosynex SA | -10.18 Million EUR | 368.156% |
Predilife S.A. | -3.82 Million EUR | 814.687% |
bioMérieux S.A. | 828.1 Million EUR | 96.702% |
Eurofins Scientific SE | 1.2 Billion EUR | 97.735% |